Trial Profile
A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Feb 2012
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 17 Jan 2012 Results published in the British Journal of Dermatology.
- 13 Nov 2010 New trial record